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Secretory protein trafficking is arrested and the Golgi apparatus
fragmented when mammalian cells enter mitosis. These changes
are thought to facilitate cell-cycle progression and Golgi
inheritance, and are brought about through the actions of
mitotically active protein kinases. To better understand how
the Golgi apparatus undergoes mitotic fragmentation we have
sought to identify novel Golgi targets for mitotic kinases.
We report in the present paper the identification of the ARF
(ADP-ribosylation factor) exchange factor GBF1 (Golgi-specific
brefeldin A-resistant guanine nucleotide-exchange factor 1) as a
Golgi phosphoprotein. GBF1 is phosphorylated by CDK1 (cyclin-
dependent kinase 1)–cyclin B in mitosis, which results in its
dissociation from Golgi membranes. Consistent with a reduced
level of GBF1 activity at the Golgi membrane there is a reduction
in levels of membrane-associated GTP-bound ARF in mitotic
cells. Despite the reduced levels of membrane-bound GBF1 and
ARF, COPI (coat protein I) binding to the Golgi membrane
appears unaffected in mitotic cells. Surprisingly, this pool of COPI
is dependent upon GBF1 for its recruitment to the membrane,
suggesting that a low level of GBF1 activity persists in mitosis.
We propose that the phosphorylation and membrane dissociation
of GBF1 and the consequent reduction in ARF-GTP levels in
mitosis are important for changes in Golgi dynamics and possibly
other mitotic events mediated through effectors other than the
COPI vesicle coat.
Key words: ADP-ribosylation factor (ARF), Golgi apparatus,
Golgi-specific brefeldin A-resistant guanine nucleotide-exchange
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INTRODUCTION
When mammalian cells enter mitosis the Golgi apparatus
undergoes extensive fragmentation, converting from a charac-
teristic ribbon of stacked cisternae into tubulovesicular clusters
and numerous free vesicles dispersed in the cytoplasm [1–3].
Golgi disassembly is concomitant with an arrest in secretory
protein trafficking, which occurs at the level of both ER
(endoplasmic reticulum)-to-Golgi and intra-Golgi trafficking [4].
Golgi disassembly and trafficking arrest are dependent upon
the action of several protein kinases, including CDK1 (cyclin-
dependent kinase 1), Plk1 (polo-like kinase 1) and MEK1
[MAPK (mitogen-activated protein kinase)/ERK (extracellular-
signal-regulated kinase) kinase 1], which in turn phosphorylate
downstream targets to bring about changes in Golgi organization
and function [2,5]. Several Golgi targets for these kinases have
been identified, with the most prominent being members of the
GRASP (Golgi reassembly and stacking protein) and golgin
families of proteins that are primarily responsible for linking or
tethering Golgi membranes during membrane traffic and Golgi
assembly [6]. Allied to protein phosphorylation, ubiquitylation of
certain proteins is also required for mitotic Golgi disassembly,
although the details remain unclear [7].
Prior to mitosis, in late G2-phase, the Golgi ribbon is
unlinked through phosphorylation of the GRASPs, which occurs
downstream of MEK1 [8,9], and membrane scission by the CtBP
(C-terminal binding protein)/BARS (brefeldin A-ribosylated
substrate) protein [10]. When cells enter mitosis, the Golgi stacks
are converted into vesicles and tubular remnants in a CDK1 and
Plk1-dependent manner [1,11,12]. An attractive model to explain
this fragmentation is that COPI (coat protein I) vesicles continue
to bud from the cisternal rims, but cannot fuse, thereby converting
Golgi cisternae into vesicles [13,14]. Phosphorylation of GRASPs
by CDK1 and Plk1 is thought to promote cisternal unstacking,
allowing better access to the COPI budding machinery and hence
more extensive vesiculation [15,16]. Phosphorylation of golgins
probably contributes to this process by promoting unstacking,
as well as preventing the tethering and subsequent fusion of
COPI vesicles [17,18]. In addition to the COPI pathway, there
is also a less well understood COPI-independent fragmentation
that has been observed both in vitro and in vivo [19,20]. This
pathway, which is thought to fragment the central core region
of the Golgi, proceeds via transient tubular intermediates that
undergo membrane scission to form smaller breakdown products.
In contrast with the COPI budding model, it has been proposed that
COPI-independent fragmentation represents the major breakdown
pathway [21]. Here, it is thought that membrane dissociation
of COPI in mitosis leads to extensive membrane tubulation
in a manner similar to treatment with the fungal metabolite
BFA (brefeldin A). It has been reported that the Golgi-derived
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tubular intermediates then fuse with the ER, merging the two
compartments [22,23]. It should be noted, however, that several
studies have failed to observe the merging of Golgi and ER in
mitosis [24–27]. Nevertheless, it remains possible that COPI-
independent tubulation is a major disassembly pathway.
COPI is recruited to the membrane through binding to
active GTP-bound ARF (ADP-ribosylation factor). Several
GEFs (guanine-nucleotide-exchange factors) for ARFs exist
in mammalian cells, including GBF1 (Golgi-specific BFA-
resistant GEF 1), which is localized to the ERGIC (ER-to-Golgi
intermediate compartment) and cis-Golgi [28–32]. Like other
ARF GEFs, GBF1 has a central Sec7 domain that catalyses
nucleotide exchange on ARF, resulting in its association with the
membrane and subsequent recruitment of downstream effectors
[33]. Several ARF GEFs, including GBF1, are targets for BFA,
which locks the GEF in an inactive membrane-bound complex
with ARF–GDP [32–34]. A major effector regulated by GBF1
is the COPI vesicle coat [30,31,35–39]. Indeed GBF1 appears to
be the sole ARF GEF responsible for COPI recruitment to the
membrane, and consequently it is vital for membrane trafficking
at the ER/Golgi interface [30,35–39]. Although GBF1 can bind to
several proteins, including Rab1b [40], the vesicle docking protein
p115 [41] and the γ -COP subunit of the COPI coat itself [42],
how it is targeted to the ERGIC and cis-Golgi remains unclear.
In the present paper we report the identification of GBF1 as
a mitotic phosphoprotein. Phosphorylation of GBF1 by CDK1
results in its reduced association with the membrane and a
concomitant decrease in levels of membrane-associated GTP-
bound ARF. Despite this, COPI remains membrane-associated
in mitosis, and surprisingly this binding appears to retain
GBF1-dependancy. Our findings suggest a role for mitotic
phosphorylation of GBF1 in regulating ARF effector proteins,
which in turn might alter Golgi membrane dynamics or other
ARF-dependent processes in mitotic cells.
EXPERIMENTAL
Materials and antibodies
All materials were from Sigma or Merck unless otherwise
stated. Protease inhibitor cocktail set III (used at a 1:250
dilution), golgicide A, roscovitine, CGP74514A, U0126 and
purvalanol A were obtained from Calbiochem. [γ -32P]ATP
was purchased from NEN. Mouse monoclonal antibodies
against GBF1 and GS28 were obtained from BD Biosciences.
Mouse anti-Myc antibody 9B11 was purchased from Cell
Signaling Technology. Rabbit polyclonal anti-GM130 (cis-
Golgi matrix protein of 130 kDa) antibody (MLO7) has been
described previously [18]. Sheep anti-golgin-84 and rabbit anti-
CASP (cytohesin-associated scaffolding protein) antibodies were
described previously [43,44]. Sheep anti-ZFPL1 (zinc-finger
protein-like 1) antibodies have been described previously [45].
Rabbit anti-p115 and anti-ARF antibodies were gifts from
Professor Elizabeth Sztul (Department of Cell Biology, University
of Alabama at Birmingham, Birmingham, AL, U.S.A.) and
Professor Shamshad Cockcroft (Department of Neuroscience,
Physiology and Pharmacology, University College London, Lon-
don, U.K.) respectively. Mouse and rabbit anti-β-COP antibodies
M3A5 and EAGE were previously raised in the laboratory of
Professor Thomas Kreis (deceased). Rabbit anti-mannosidase I
was a gift from Professor Francis Barr (University of Liverpool,
Liverpool, U.K.). Sheep anti-GST (glutathione transferase)
antibodies have been described previously [46]. Fluorophore-
conjugated (Alexa Fluor® 594 and Alexa Fluor® 488) and HRP
(horseradish peroxidase)-conjugated secondary antibodies were
purchased from Molecular Probes and Tago Immunologicals
respectively.
Molecular biology and protein expression
Standard molecular biology techniques were used for all
constructs; primer sequences are available upon request from
the corresponding author. All constructs were verified by DNA
sequencing. Full-length human GBF1 cDNA in pcDNA4/Myc-
His was kindly provided by Professor Elizabeth Sztul. cDNA
encoding full-length GBF1 and a truncation lacking the C-
terminal 59 amino acids were cloned into the EcoRI and XhoI
sites of pcDNA3.1 and an N-terminal Myc-tag was added
using QuikChange® mutagenesis (Stratagene). DNA encoding
N-terminally Myc-tagged wild-type full-length and the truncated
version (C59) of GBF1 were inserted into EcoRI and XhoI
sites of pMXs-puro (a gift from Professor Toshio Kitamura,
University of Tokyo, Tokyo, Japan) for retroviral expression.
cDNA encoding Myc-tagged full-length or the C59 mutant
were cloned into the EcoRI and NotI sites of pAcGHLT for
baculovirus-driven expression of GST-tagged protein in insect
cells. cDNA encoding Plk1 PBD (polo box domain; amino acids
305–603) was cloned from a human liver cDNA library into the
EcoRI and XhoI sites of pGEX 4T-1. The VHS-GAT domain
of GGA3 (amino acids 1–313) was cloned from a human liver
cDNA library into the EcoRI and XhoI sites of pGEX 4T-1.
Bacterial expression and purification of GST-tagged Plk1 PBD
and GGA3 constructs was performed using standard methods.
GST-tagged GBF1 was expressed in Sf9 cells using the BacMagic
system (Novagen). Cells were harvested from four 162 cm2
flasks 1 day post-infection, and lysed in 20 ml of 50 mM sodium
phosphate (pH 8.0), 0.3 M NaCl and 1%Triton X-100 containing
protease inhibitors by sonication. Lysates were clarified by
centrifugation (100000 g for 1 h at 4 ◦C) and incubated with
glutathione–Sepharose for 1 h at 4 ◦C. After washing, GST–GBF1
was eluted from the beads using 20 mM reduced glutathione,
50 mM Tris/HCl (pH 7.4) and 150 mM NaCl. Glycerol was added
to 10% and the purified protein was snap-frozen and stored
at −80 ◦C. ε-COP–GFP (GFP is green fluorescent protein) [47]
(kindly provided by Dr Theresa Ward, London School of Hygeine
and Tropical Medicine, University of London, London, U.K.,
and Professor Jennifer Lippincott-Schwartz, National Institutes
of Health, Bethesda, MD, U.S.A.) was amplified by PCR and
subcloned into pLVX-Puro (Clontech) using EcoRI-XhoI sites,
generating a lentivirus from which ε-COP–GFP was stably
expressed in NRK (normal rat kidney) cells. Plasmid encoding
GFP-tagged wild-type ARF1 was kindly provided by Professor
Jennifer Lippincott-Schwartz.
Retroviral infection of mammalian cells
Retroviral infection was carried out as reported previously
[48]. The packaging cell line Plat-A (from Professor Toshio
Kitamura, University of Tokyo, Tokyo, Japan) was kept in DMEM
(Dulbecco’s modified Eagle’s medium) containing 1 μg/ml
puromycin and 10 μg/ml blasticidin. Retroviral transfer plasmids
were transfected using FuGENE® 6 (Roche Biochemicals) into
Plat-A cells. After 48 h, conditioned media were filtered through a
0.45 μm filter and used as a virus stock. For infection, target cells
were cultured with a virus stock diluted into an equal volume
of DMEM/10% FCS (fetal calf serum) containing 8 μg/ml
Polybrene. Stable infectants of HeLa cells were generated by
selection in DMEM containing 2 μg/ml puromycin. Cells were
analysed at 10–14 days after infection.
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Fluorescence microscopy
Adherent HeLa or NRK cells were grown on glass coverslips
at 37 ◦C and 5% CO2 in DMEM containing 10% FCS. For
the enrichment of mitotic NRK cells, 2.5 μg/ml aphidicolin
was added to the medium for 14–16 h to arrest cells at the
G1/S boundary. Cells were washed five or six times to remove
the residual drug and incubated in fresh medium for 5–7 h
to allow progression into mitosis. Unsynchronized HeLa cells
were transfected with ARF1–GFP 16–20 h before fixation using
FuGENE® 6 according to the manufacturer’s instructions. Cells
were fixed in paraformaldehyde [3% (w/v) in PBS] for 20 min
at room temperature (22 ◦C), quenched with 10 mM glycine
(pH 8.5) in PBS and permeabilized with 0.1% Triton X-100 in
PBS for 5 min at room temperature. Labelling was performed by
sequentially incubating with primary then secondary antibodies
diluted in PBS containing 0.5 mg/ml BSA for 20 min at room
temperature. Images were acquired using an Olympus BX60
microscope equipped with a coolSNAP EZ CCD (charge-coupled
device) camera using Metaview software (Universal Imaging) and
processed using Adobe Photoshop CS.
Incubations with interphase and mitotic cytosol
Incubations of rat liver Golgi with interphase or mitotic
cytosol prepared from HeLa S3 cells was carried as described
previously [44]. Briefly, 10 μg of Golgi membranes were
incubated with 40 μl of interphase or mitotic cytosol [at
9 mg/ml in buffer A: 20 mM 2-glycerophosphate, 15 mM EGTA,
10 mM magnesium acetate, 50 mM potassium acetate, 2 mM
ATP, 1 mM DTT (dithiothreitol) and 0.2 M sucrose] in the
presence of an ATP-regeneration system (10 mM creatine
phosphate and 20 μg/ml creatine kinase) for various times at
30 ◦C. Membranes were re-isolated by centrifugation (100000 g
for 10 min at 4 ◦C) through a 0.4 M sucrose cushion. In
certain experiments, 10 μM staurosporine or 2 μl (20 units)
of calf intestinal alkaline phosphatase (NEB) was included
in the incubation. In some experiments the ATP-regeneration
system was omitted and [γ -32P]ATP was added at 0.5 μCi/μl.
In-vitro-translated 35S-labelled GBF1 was made using the TNT®-
coupled reticulocyte lysate system (Promega) according to the
manufacturer’s instructions. In-vitro-translated protein (0.5 μl)
was incubated with 20 μl of interphase or mitotic cytosol
(2 mg/ml in buffer A with ATP-regeneration system) for 30 min
at 30 ◦C. GST-tagged GBF1 (1 μg) or Protein S-tagged GM130
was bound to 10 μl of glutathione or Protein S-coupled beads
and incubated with 20 μl of interphase or mitotic cytosol at
2 or 9 mg/ml containing 0.5 μCi/μl [γ -32P]ATP for 30 min at
30 ◦C. In some cases, parallel incubations were performed by
adding 10 μg of histone type III-S (Sigma). Inhibitors were added
from 100×concentrated stock solutions in DMSO, while controls
contained DMSO vehicle only. Cyclin B/CDK1 was purified from
insect cells and added to give 0.4× and 1.0× of added histone
kinase activity of mitotic cytosol. Proteins were solubilized in SDS
sample buffer and analysed by SDS/PAGE and autoradiography
on BioMax MS film (Kodak).
Immunoprecipitation of GBF1 and far-Western blotting
Interphase or mitotic rat liver Golgi membranes were extracted
in extraction buffer [20 mM Tris/HCl, 50 mM KCl, 5 mM MgCl2
and 0.5% Triton X-100 (pH 7.4)] containing protease inhibitors
for 1 h on ice prior to clarification by centrifugation (18000 g for
10 min at 4 ◦C). Clarified Golgi membrane extracts, or interphase
or mitotic HeLa S3 cytosol (containing 0.5% Triton X-100 and
protease inhbitors) were incubated with 2 μg of mouse anti-GBF1
antibody followed by 20 μl of Protein G–Sepharose for 2 h at
4 ◦C. After washing, bound proteins were eluted and analysed by
SDS/PAGE and autoradiography, Western blotting or far-Western
blotting. In some cases, immunoprecitates were incubated with
2 μl (20 units) of calf intestinal alkaline phosphatase in 50 mM
Tris/HCl (pH 7.9), 0.1 M NaCl, 10 mM MgCl2 and 1 mM DTT
for 30 min at 37 ◦C prior to elution. Far-Western blotting was
performed by transferring proteins on to nitrocellulose membrane,
blocking the membrane in PBS containing 0.2% Tween 20 and
5% non-fat milk powder, followed by incubation with 1 μg/ml
GST-tagged Plk1 PBD in PBS containing 0.2% Tween 20 and
2% non-fat milk powder for 3 h at room temperature. Bound
Plk1 PBD was detected by incubating with anti-GST antibodies
followed by HRP-conjugated secondary antibodies and ECL
(enhanced chemiluminescence).
Identification of Plk1 PBD-binding proteins
For large-scale identification of Golgi Plk1 PBD-binding proteins,
200 μg of rat liver Golgi membranes was incubated with 500 μl
of mitotic cytosol (9 mg/ml in buffer A) containing 0.5 μCi/μl
[γ -32P]ATP for 30 min at 30 ◦C. Membranes were re-isolated by
centrifugation through a 0.4 M sucrose cushion for 10 min at
55000 rev./min in a TLA55 rotor. Membranes were extracted
in extraction buffer for 1 h on ice, clarified by centrifugation
(18000 g for 10 min at 4 ◦C), and incubated with 10 μg of GST–
Plk1 PBD bound to glutathione–Sepharose for 1 h at 4 ◦C. Beads
were washed, and bound proteins were analysed by SDS/PAGE
and autoradiography or Western blotting. Radiolabelled proteins
were excised from rehydrated gel slices and identified using
MS by the University of Manchester Faculty of Life Sciences
Biomolecular Analysis Facility.
Kinase inhibitor treatment of HeLa cells
Treatment with kinase inhibitors was performed on adherent HeLa
cells grown in 12-well plates. Cells were arrested in mitosis
with 100 ng/ml nocodazole for 22–24 h at 37 ◦C and treated with
the required concentration of kinase inhibitor for an additional
1 h at 37 ◦C. Cells were harvested, washed in ice-cold PBS
and extracted in 100 μl of extraction buffer containing 20 mM
2-glycerophosphate and protease inhibitors. Samples were
analysed by SDS/PAGE and Western blotting.
Fractionation of HeLa cells
HeLa S3 cells were cultured in 250 ml spinner flasks. Mitotic cells
were prepared by incubating in 100 ng/ml nocodazole for 22–
24 h at 37 ◦C. In some experiments BFA was added at 5 μg/ml for
10 min prior to harvesting. Cells were harvested by centrifugation
(900 g for 10 min), washed in PBS and, after swelling in
0.4× lysis buffer [1×lysis buffer is 20 mM Hepes (pH 7.4),
50 mM KCl, 5 mM MgCl2, 1 mM DTT and 0.2 M sucrose],
were lysed in 1× lysis buffer containing protease inhbitors by
passing through a ball-bearing homogenizer (8.02 mm barrel with
8.01 mm ball). Lysates were then cleared by centrifugation at
1000 g for 10 min to generate a post-nuclear supernatant. This
was subsequently layered on to lysis buffer containing 0.4 M
sucrose, and cytosol and membrane fractions were generated by
centrifugation at 50000 rev./min for 15 min in a TLS55 rotor.
Retrovirally transduced adherent HeLa cells expressing Myc-
tagged GBF1 were scraped into PBS, washed as above and
homogenized in lysis buffer by passing through a 25 gauge needle.
Resulting homogenates were fractionated as above. Quantification
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of bands was performed by densitometry using ImageJ software
(NIH).
GST–GGA3 binding experiments
Interphase or mitotic HeLa S3 cells (25 ml of suspension culture)
were incubated without or with 10 μg/ml BFA for 1 h at
37 ◦C prior to washing in ice-cold PBS and lysis in 800 μl of
50 mM Tris/HCl (pH 7.5), 0.1 M NaCl, 5 mM MgCl2 and 1%
Triton X-100 containing protease inhibitors. After clarification by
centrifugation (18000 g for 10 min at 4 ◦C), 300 μl of extract was
incubated with 30 μl of glutathione–Sepharose containing 50 μg
of bound GST or GST–GGA3 VHS-GAT domain for 1 h at 4 ◦C.
After washing the beads, bound ARF was detected by Western
blotting. Quantification of bands was performed by densitometry
using ImageJ software.
FRAP (fluorescence recovery after photobleaching)
NRK cells stably expressing ε-COP–GFP were grown on MatTek
dishes and synchronized at ∼40% confluence with 2 mM
thymidine for 16 h. Cells were washed with PBS and incubated in
fresh DMEM for 8 h. FRAP was performed between 10 and 12 h
after the second synchronization. Cells were imaged at 37 ◦C with
the PerkinElmer UltraVIEW ERS 6FE confocal system attached
to a Leica DM I6000 inverted epifluorescence microscope
encompassing Yokogawa CSU22 spinning disc technology and
a Hamamatsu C9100-50 EM-CCD camera controlled by Volocity
5 (Improvision) acquisition software. Cells were imaged in MEM
(minimal essential medium) without Phenol Red, supplemented
with 30 mM Hepes (pH 7.4), 0.5 g · l−1 sodium bicarbonate
and 10% FCS using a 63× 1.3 NA (numerical aperture)
Plan-Apochromat objective. Photobleaching of ε-COP–GFP was
performed with a ∼500 nm diameter circular region. Pre-bleach
images were collected for 5 s and post-bleach images were
collected for 60 s using 30% AOTF (acousto-optic tunable filter)
power and low laser intensity. For ε-COP–GFP, FRAP was
performed at a rate of five time points per 1 s, and region-of-
interest bleaching with five iterations of the 488 and 514 nm
lasers at 100% AOTF power. Punctae that moved out of focus or
moved over 500 nm during the photobleaching series could not
be analysed. Fluorescence recovery in the bleached region during
the time series was quantified using Volocity 5 (Improvision)
FRAP analysis software and exported for analysis to GraphPad
Prism 4.02. Recycling kinetics were obtained by curve fitting to
a one-phase exponential (eqn 1):
f (t) = A × (1 − e − kt ) + B (1)
Where A is the mobile fraction, B is the fluorescence directly
after photobleaching (%), and k is the rate of fluorescence
recovery from which t1/2 is determined [t1/2=ln(2)/k]. Statistical
significance was tested using S.D. and Student’s unpaired t test.
RESULTS
Identification of GBF1 as a mitotic phosphoprotein
To identify novel mitotic Golgi phosphoproteins we used a
previously described in vitro assay in which rat liver Golgi
membranes are incubated with cytosol from interphase or mitotic
HeLa cells [14,43]. Golgi extracts were then prepared and
incubated with immobilized Plk1 PBD before MS identification
of bound proteins. The Plk1 PBD is a phosphoserine/threonine-
binding domain that targets Plk1 to various mitotic substrates
[49,50]. We used binding to the Plk1 PBD to simplify the
profile of Golgi phosphoproteins, as well as to identify new
potential Golgi-localized Plk1-binding partners. As shown in
Figure 1(A) (top panel) several mitotically phosphorylated Golgi
proteins bound to wild-type Plk1 PBD, but not a H538A/K540M
mutant unable to bind phosphorylated ligands [49]. Among the
specifically bound proteins were GRASP65, previously identified
as a Plk1 PBD ligand [51], and GM130, which may bind Plk1
PBD indirectly via its association with GRASP65 (Figure 1A,
open arrowheads). A minor phosphoprotein running at 210 kDa
was identified as GBF1, the Golgi-associated ARF nucleotide-
exchange factor (Figure 1A, filled arrowhead). The identity of
GBF1 as a Plk1 PBD-binding protein was confirmed by Western
blotting (Figure 1A, bottom panel). GBF1 bound to wild-type, but
not mutant, Plk1 PBD, with stronger binding observed under mito-
tic conditions. These results suggest that GBF1 undergoes
mitosis-specific phosphorylation. This was tested by incubating
Golgi membranes with cytosol in the presence of [γ -32P]ATP
and immunoprecipitating the protein with specific antibodies. As
shown in Figure 1(B), GBF1 was phosphorylated by mitotic
cytosol. Phosphorylation is quantitative, causing a molecular-
mass shift in the entire pool of cytosolic GBF1 (Figure 1C).
Interestingly, we also observed a lower level of interphase
phosphorylation (Figures 1B and 1C). Far-Western blotting
confirmed that GBF1 can directly bind to the Plk1 PBD, and that
it preferentially binds after mitotic phosphorylation (Figure 1C).
Treatment of mitotic GBF1 with alkaline phosphatase abolished
this binding, indicating that it is dependent upon phosphorylation.
The alkaline phosphatase-sensitive molecular-mass shift of
mitotic compared with interphase GBF1 was also seen in total
cell extracts, confirming that GBF1 is phosphorylated in vivo
(Figure 1D; see also Figure 3C).
GBF1 is phosphorylated by CDK1
To identify the kinase responsible for mitotic GBF1
phosphorylation, we first prepared recombinant N-terminally
GST-tagged full-length protein from insect cells. As shown in
Figure 2(A), GST–GBF1 was phosphorylated by mitotic cytosol.
The amount of phosphorylation was comparable with that of
GM130, one of the major Golgi phosphoproteins [12,52]. As
expected, and in contrast with GM130, GST–GBF1 was also
phosphorylated by interphase cytosol, although to a lower level
than mitotic cytosol (Figure 2A). Many PBD-binding proteins
rely on phosphorylation by proline-directed kinases, most notably
CDK1 in early mitosis, to generate the PBD recognition site [50].
We therefore tested whether GST–GBF1 phosphorylation was
sensitive to the CDK1 inhibitors roscovitine and CGP74154A.
Mitotic phosphorylation of GST–GBF1 was sensitive to both
inhibitors, with a similar level of inhibition to that seen with
the model CDK1 substrate histone III-S (Figure 2B). To examine
this further, we used another measure of GBF1 phosphorylation,
namely its shift in mobility upon SDS/PAGE. In-vitro-translated
GBF1 was incubated with interphase or mitotic cytosol in the
absence or presence of various kinase inhibitors. The mobility-
shift of GBF1, and hence its phosphorylation, was prevented by
roscovitine and CGP7415A, but not by the MEK1 inhibitor U0126
(Figure 2C). This is consistent with phosphorylation by CDK1, but
not MEK1. To determine whether CDK1 phosphorylates GBF1
in vivo, mitotically arrested HeLa cells were treated with the CDK
inhibitors CGP7415A and purvalanol A and phosphorylation
monitored by mobility-shift. Both CDK inhibitors reduced the
mobility-shift of GBF1 in mitotic cells, indicating inhibition of
phosphorylation, whereas U0126 had no effect (Figure 2D). The
inhibitor effects were similar to those upon the known CDK1
substrate GM130 [12], consistent with CDK1 phosphorylating
c© The Authors Journal compilation c© 2010 Biochemical Society
Mitotic phosphorylation of GBF1 405
Figure 1 Phosphorylation of GBF1 in mitosis
(A) Rat liver Golgi membranes were incubated with interphase (I) or mitotic (M) cytosol in the presence of [γ -32P]ATP for 30 min at 30◦C prior to extraction and incubation with GST alone or
GST–Plk1 PBD wild-type (wt) or H538/K540 substrate binding mutant (HKmut). Total extract and bound proteins were analysed by autoradiography (AR, top panel) or Western blotting with an antibody
against GBF1 (WB, bottom panel). The positions of GBF1, GM130 and GRASP65 on the autoradiograph, as identified by MS, are indicated. (B) Interphase (I) or mitotically (M) phosphorylated Golgi
extracts were immunoprecipitated with ant-GBF1 antibody (IP). Total extract (Ex), unbound proteins (UB) and immunoprecipitated GBF were analysed by autoradiography (AR, top panel) or Western
blotting with anti-GBF1 antibody (WB, bottom panel). (C) GBF1 was immunoprecipitated from interphase (I) or mitotic (M) cytosol and incubated in the absence (−) or presence (+) of alkaline
phosphatase (AP) before transfer to nitrocellulose and Western blotting with anti-GBF1 antibody (WB) or far-Western blotting with recombinant PBD wild-type (wt) or HK mutant (HKmut). (D) GBF1
was immunoprecipitated from interphase (I) or mitotic (M) sHeLa cells and incubated in the absence (−) or presence (+) of alkaline phosphatase (AP) before Western blotting (WB) with anti-GBF1
antibody. For (A and B), the molecular mass in kDa is indicated on the left-hand side.
GBF1 in vivo (Figure 2D). To confirm that CDK1 can directly
phosphorylate GBF1, GST–GBF1 was incubated with purified
recombinant CDK1–cyclin B in the presence of [γ -32P]ATP. As
shown in Figure 2(E), GST–GBF1 was phosphorylated by CDK1-
cyclin B to a level comparable with that seen with mitotic cytosol.
We conclude from these experiments that GBF1 is a substrate for
the mitotic kinase CDK1.
Dissociation of GBF1 from Golgi membranes in mitosis
We next wanted to address the significance of GBF1
phosphorylation. We noticed that the amount of membrane-
associated GBF1 was reduced following incubation with mitotic
cytosol (Figures 1A and 1B), suggesting that phosphorylation
may promote membrane dissociation. We investigated this in
more detail by performing a time-course experiment. GBF1
rapidly dissociated from Golgi membranes incubated with mitotic
cytosol, but not from those incubated with interphase cytosol
(Figure 3A). The kinetics of dissociation were similar to those
of p115, a golgin that is released from membranes upon
CDK1-mediated phosphorylation of GM130 [18,53]. Release of
GBF1 was blocked by the general kinase inhibitor staurosporine
or incubation with alkaline phosphatase, indicating that it is
phosphorylation-dependent (Figure 3B). Analysis of subcellular
fractions prepared from interphase and mitotic HeLa cells
confirmed that membrane dissociation also occurs in vivo
(Figure 3C; see also Figures 6B and 6C).
To further examine membrane dissociation of GBF1 in vivo,
NRK cells were synchronized using an aphidicolin block/release
protocol and analysed at various mitotic stages by
immunofluorescence microscopy. The amount of GBF1 localized
to the Golgi apparatus appeared reduced in late prophase and
prometaphase cells compared with neighbouring interphase cells
(Figure 4A, top panel). There was, however, residual Golgi
staining evident at these mitotic stages, albeit with reduced
intensity compared with the membrane-associated Golgi markers
golgin-84 and GM130 (Figures 4A and Supplementary Figure
S1A at http://www.BiochemJ.org/bj/427/bj4270401add.htm). In
metaphase, when the Golgi is highly fragmented, GBF1 staining
appeared mostly diffuse in the cytoplasm (Figure 4A, bottom
panel). A diffuse haze is also seen with golgin-84, which
probably reflects the conversion of Golgi cisternal rims into
numerous dispersed vesicles [20,24,27,54]. The Golgi matrix
protein GM130 remains associated with Golgi remnants that are
readily observed at the light-microscope level in metaphase cells
[52]. These fragments are largely devoid of GBF1, although a low
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Figure 2 GBF1 is phosphorylated by CDK1
(A) Equal amounts of recombinant GST–GBF1 or Protein S-tagged GM130 were immobilized on beads and incubated with interphase (I) or mitotic (M) cytosol in the presence of [γ -32P]ATP for
30 min at 30◦C. Bound proteins were analysed by SDS/PAGE and autoradiography (AR). (B) Immobilized GST–GBF1 or purified histone type III-S were incubated with interphase (I) or mitotic (M)
cytosol containing [γ -32P]ATP in the absence or presence of roscovitine or CGP74154A at the concentrations indicated. Phosphorylation was monitored by SDS/PAGE and autoradiography (AR).
(C) 35S-labelled in-vitro-translated GBF1 was incubated with interphase (I) or mitotic (M) cytosol in the absence or presence of 500 μM roscovitine (Rosco), 50 μM CGP74154A (CGP) or 500 μM
U0126 as indicated for 30 min at 30◦C prior to SDS/PAGE and fluorography. (D) Interphase (I) or mitotic (M) sHeLa cells were treated with U0126 (10 μM), CGP74154A (CGP, 2, 10 or 50 μM)
or purvalanol A (Purv, 10 μM) for 1 h at 37◦C prior to extraction and analysis by Western blotting (WB) with antibodies against GBF1 and GM130. (E) Immobilized GST–GBF1 or purified histones
were incubated with interphase (I) or mitotic (M) cytosol or purified CDK1–cyclin B (added at 0.4× and 1× equivalents of the mitotic cytosol histone kinase activity) in the presence of [γ -32P]ATP
for 30 min at 30◦C. Phosphorylation was monitored by SDS/PAGE and autoradiography (AR).
level of residual staining persists in some cells (Figure 4B). GBF1
remains diffuse in anaphase, and is largely absent from GM130-
positive Golgi clusters (Figure 4B). During telophase, when
the Golgi undergoes reassembly and secretory membrane traffic
resumes [55], GBF1 is again abundant at the Golgi apparatus
(Figure 4C). Similar results were seen in unsynchronized HeLa
cells (Supplementary Figure S1B).
The GBF1 C-terminus regulates its phosphorylation and membrane
association
GBF1 contains many potential CDK1 phosphorylation sites,
several of which are clustered in its C-terminus. To determine
whether these residues are mitotically phosphorylated, we
generated a deletion mutant lacking the extreme C-terminal 59
residues and tested for phosphorylation by mitotic cytosol. As
shown in Figure 5(A), deletion of the C-terminal 59 residues
abolished the molecular-mass shift of in-vitro-translated GBF1
seen upon incubation with mitotic cytosol. Similarly, deletion
of the C-terminus significantly reduced the amount of mitotic
phosphorylation of GST–GBF1, but had little effect on the level
of interphase phosphorylation (Figure 5B). Thus the C-terminus of
GBF1 is required for its phosphorylation in mitosis. We decided
to use this information to confirm that it is phosphorylation of
GBF1 itself, rather than other proteins, that regulates its membrane
association. Wild-type and C-terminally truncated GBF1 were
expressed at low levels in interphase or mitotic HeLa cells by
retroviral transduction, and the amount of membrane-associated
GBF1 assessed by subcellular fractionation. Expression of wild-
type GBF1 or the C59 mutant had no effect upon mitotic
entry, as revealed by FACS analysis (results not shown). Wild-
type GBF1 dissociated from mitotic membranes as expected,
whereas the C59 mutant remained bound during both interphase
and mitosis (Figure 5C). This suggests that the C-terminal 59
residues of GBF1 are required for regulation of its membrane
binding through mitotic phosphorylation. Unfortunately further
attempts to map the C-terminal residues important for regulation
of membrane binding were unsuccessful. Mutagenesis of all
eight potential phosphorylation sites to alanine failed to affect
mitotic phosphorylation (results not shown), suggesting that the
C-terminus is required for kinase docking, either directly as a
binding site or through maintaining the correct three-dimensional
structure of the protein.
Membrane association of ARF and COPI in mitosis
GBF1 appears to be the only ARF GEF that is responsible
for membrane recruitment of COPI [35,36,38,39]. We therefore
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Figure 3 Dissociation of GBF1 from Golgi membranes in mitosis
(A) Rat liver Golgi membranes were incubated with interphase (I) or mitotic (M) cytosol for the times indicated, re-isolated by centrifugation and analysed by Western blotting (WB) with antibodies
against GBF1, p115 and mannosidase I (Mann I). (B) Rat liver Golgi membranes were incubated with buffer, interphase (I) or mitotic (M) cytosol alone or in the presence of 10 μM staurosporine (St)
or alkaline phosphatase (AP) for 30 min at 30◦C, re-isolated and analysed by Western blotting (WB). (C) Interphase (I) and mitotic (M) sHeLa cells were separated into cytosol (Cyt) and membrane
(Mem) fractions and subjected to Western blotting (WB) with the antibodies indicated. Note that 10-fold more membrane fraction was loaded relative to cytosol.
predicted that reduced levels of GBF1 at the Golgi in mitosis
would affect membrane binding of both ARF and COPI. This
was first analysed using the in vitro Golgi assay. To our
surprise, both ARF and COPI remained membrane-associated
for the duration of the incubation, even though GBF1 was
rapidly dissociated from the membrane (Figure 6A). We next
investigated whether this was also true in vivo. Subcellular
fractions were prepared from HeLa cells and analysed by Western
blotting. As expected, both GBF1 and p115 were dissociated
from the membrane in mitosis (Figure 6B). As seen in vitro,
COPI remained membrane-bound in mitotic cells (Figures 6B
and 6C). We could also show the membrane association of
COPI in early mitosis by immunofluorescence microscopy
(Figure 6D). In contrast with what was observed in vitro,
ARF appeared to partially dissociate from the membrane in
mitotic cells (Figures 6B and 6C). Fluorescence microscopy of
transiently expressed ARF1–GFP also indicated a reduced level
of membrane association in mitosis (Supplementary Figure S2
at http://www.BiochemJ.org/bj/427/bj4270401add.htm). These
results suggest that levels of ARF–GTP may be reduced in mitosis,
which would be consistent with a reduced amount of ARF GEF
activity in mitotic cells. To test this possibility extracts were
prepared from interphase and mitotic cells, and binding to the
ARF effector GGA3 was used to monitor ARF–GTP levels. As
shown in Figures 6(E) and 6(F), there was a reduction in the levels
of ARF–GTP in mitotic extracts. This result is consistent with a
loss of GBF1 from the membrane resulting in reduced nucleotide-
exchange on ARF, which in turn causes reduced membrane
binding. In both interphase and mitotic conditions BFA, which
inhibits several ARF GEFs [33], causes a large decrease in ARF–
GTP levels, suggesting that there remains significant total ARF
GEF activity in mitotic cells.
Since reduced GBF1 activity would be predicted to result in
dissociation of COPI from the membrane, our results suggested
that COPI may be uncoupled from GBF1 in mitosis. To
investigate this possibility, mitotic cells were treated with BFA
for 5 min and COPI localization was studied. As observed
previously, BFA treatment prevented Golgi dispersion in prometa-
phase [56], resulting in distinct golgin-84-positive foci in
metaphase cells (Figure 7A). The Golgi fragments were devoid of
COPI, indicating that COPI recruitment remains BFA-sensitive in
mitosis. A similar effect was observed with transiently expressed
ARF–GFP, indicating that the low level of ARF recruitment in
mitosis remains BFA-sensitive (Supplementary Figure S2). The
simplest interpretation is that COPI still requires GBF1 for its
recruitment to the membrane in mitosis, and that BFA inhibits
GBF1 in mitotic cells. If this were the case we might expect
BFA to lock GBF1 on to the membrane in an inactive complex
with ARF–GDP, as is observed in interphase [32,34,35]. Note
that the bulk of ARF is cytosolic under these conditions [32].
Analysis of GBF1 in BFA-treated cells confirmed that BFA did
indeed lock GBF1 on to the membrane in mitosis, giving a
clear labelling of Golgi fragments by microscopy (Figure 7A)
and a redistribution to the membrane fraction upon subcellular
fractionation (Figure 7B). We observed similar effects upon COPI
(and GBF1) distribution with the more specific GBF1 inhibitor
golgicide A [39], confirming that these effects are not due to
inhibition of other ARF GEFs in mitotic cells (results not shown).
These results suggest that, even though GBF1 distribution shifts to
the soluble pool in mitosis, it continues to cycle on and off Golgi
membranes such that it can be trapped in an inactive complex with
ARF–GDP on membranes upon BFA or golgicide A treatment.
This complex would contain phosphorylated GBF1, since the
level of GBF1 phosphorylation in mitotic cells is unaffected by
treatment with BFA or golgicide A (results not shown). Taken
together our results suggest that, despite its reduced membrane
binding, GBF1 provides sufficient ARF exchange activity to
allow continued recruitment of COPI on to Golgi membranes
in mitotic cells. In line with this, FRAP analysis of GFP-tagged
COPI indicates that its membrane recruitment occurs at a similar
rate in mitosis to that in interphase, consistent with a similar
mode of recruitment during both cell-cycle stages (Supplementary
Figure S3 at http://www.BiochemJ.org/bj/427/bj4270401add.
htm).
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Figure 4 Localization of GBF1 during stages of mitosis
(A) NRK cells were synchronized to enrich for mitotic cells and analysed at the mitotic stages indicated by immunofluorescence microscopy with antibodies against GBF1 (green) and the cis-Golgi
marker golgin-84 (red). (B) Synchronized NRK cells were double-labelled with antibodies against GBF1 (green) and the cis-Golgi matrix protein GM130 (B) or golgin-84 (C) (red). DNA is in blue.
Asterisks indicate interphase cells. Scale bar, 10 μm.
Figure 5 Phosphorylation of the GBF1 C-terminus regulates membrane binding
(A) In-vitro-translated (IVT) 35S-labelled wild-type (WT) full-length GBF1 or a mutant lacking the C-terminal 59 amino acids (C59) was incubated with interphase (I) or mitotic (M) cytosol for
30 min at 30◦C and analysed by fluorography. (B) GST-tagged wild-type (WT) full-length or the C59 mutant was incubated with interphase (I) or mitotic (M) cytosol in the presence of [γ -32P]ATP
for 30 min at 30◦C and analysed by autoradiography (AR). (C) Myc-tagged wild-type (WT) or the C59 mutant GBF1 was expressed in HeLa cells by retroviral infection and membrane fractions
were recovered from the cells analysed by Western blotting (WB) with antibodies against the Myc tag or CASP.
c© The Authors Journal compilation c© 2010 Biochemical Society
Mitotic phosphorylation of GBF1 409
Figure 6 Membrane association of ARF and COPI in mitosis
(A) Rat liver Golgi membranes were incubated with mitotic cytosol (M) for the times indicated at 30◦C, re-isolated and analysed by Western blotting (WB) with the antibodies indicated. (B) Interphase
(I) and mitotic (M) HeLa cells were fractionated into cytosol (Cyt) and membrane (Mem) fractions and subjected to Western blotting (WB) with the antibodies indicated. Note that 10-fold more
membrane fraction was loaded relative to cytosol. (C) Quantification of membrane association of the indicated proteins. Results show the amount of protein bound to mitotic membranes expressed
as a percentage of that bound in interphase, normalized to the recovery of membranes as monitored by CASP. Values are means + S.D. (n = 4–7). (D) NRK cells were synchronized and analysed
by immunofluorescence microscopy with antibodies against COPI (green) and golgin-84 (red). DNA is in blue. The asterisk marks an interphase cell. Scale bar, 10 μm. (E) Extracts prepared from
interphase (I) or mitotic (M) sHeLa cells were incubated with beads containing GST or GST–GGA3, and bound ARF was detected by Western blotting (WB). The asterisk indicates a cross-reacting
protein bound to the beads. (F) Quantification of ARF bound to GST–GGA3, indicating ARF–GTP levels. Values are means+S.D. (n = 4). I, interphase; M, mitotic.
DISCUSSION
In the present study we have identified GBF1 as a novel
mitotic phosphoprotein. Phosphorylation is quantitative; that is,
the entire pool of cellular GBF1 is phosphorylated in mitotic
cells. Phosphorylation causes membrane dissociation of GBF1,
resulting in a redistribution to the cytoplasm. Since GBF1 is
thought to catalyse nucleotide-exchange on ARF at the membrane,
this would be predicted to reduce cellular ARF–GTP levels, which
is what we observed in our experiments. However, membrane-
bound levels of COPI appeared unaffected, suggesting that low
levels of GBF1 activity persist in mitosis that are sufficient to
recruit COPI to the membrane. In line with this, the dynamics
of COPI membrane association are similar in both interphase
and mitotic cells. Thus the pool of ARF1 responsible for COPI
recruitment appears unaffected by membrane dissociation of
GBF1 in mitosis. This pool of ARF is probably important
for driving the COPI-mediated vesiculation of the Golgi as
it undergoes mitotic disassembly [14,57]. Interestingly, COPI
subunits can undergo phosphorylation in mitosis [58,59] and,
consistent with this, the COPI subunit β-COP undergoes a
molecular-mass shift under mitotic conditions, although this could
correspond to another post-translational modification, such as
ubiquitylation [57]. The significance of these modifications is
so far unclear, but our results suggest they do not have a major
effect on COPI membrane recruitment.
Two models have been proposed to explain the Golgi
fragmentation that occurs in mitosis. These are the COPI budding
c© The Authors Journal compilation c© 2010 Biochemical Society
410 Y. Morohashi and others
Figure 7 Effects of BFA on GBF1 and COPI in mitosis
(A) NRK cells were synchronized to enrich for mitotic cells and incubated with 5 μg/ml BFA for 5 min at 37◦C prior to fixation and labelling with the antibodies indicated. Left-hand panels are
green, middle panels are red; in the merge, DNA is in blue. Asterisks indicate interphase cells. Scale bar, 10 μm. (B) Interphase (I) or nocodazole-arrested mitotic (M) sHeLa cells were treated with
or without 5 μg/ml BFA for 10 min at 37◦C, lysed and post-nuclear supernatants (PNS) fractionated into post-nuclear cytosol and membrane fractions prior to analysis by Western blotting (WB)
with the antibodies indicated. ZFPL1 is an integral Golgi membrane protein and is used as a membrane marker. Note that 10-fold more membrane fraction was loaded relative to PNS (post-nuclear
supernatant) and cytosol.
model, in which the cisternae are converted into vesicles by
continual COPI budding [13], or the BFA-like fragmentation
model, in which loss of ARF and COPI from the membrane cause
extensive tubulation and eventually Golgi dispersion, which may
be followed by fusion with the ER [21,22]. The loss of GBF1
from the membrane would appear to support the latter model.
However, as described above, we do not see a loss of COPI from
the membrane, in contrast with Altan-Bonnet et al. [21], who
used fluorescence imaging techniques to study COPI membrane
association [21]. We did see a reduction in ARF binding to the
membrane, but there remained a pool of membrane-associated
GTP-bound ARF in mitotic cells. Thus our findings do not support
a BFA-type Golgi dispersion in mitosis, and are more consistent
with a COPI-mediated fragmentation mechanism, as described by
others [14,57]. If phosphorylation and membrane dissociation of
GBF1 does not affect membrane-bound levels of COPI, what is its
significance? ARF is responsible for the recruitment of numerous
effectors to the Golgi membrane [60,61], including some proteins
that appear to have non-Golgi roles in mitosis [21]. Thus, as
originally suggested by Altan-Bonnet et al. [21], the regulation
of ARF in mitosis, which we have shown occurs through GBF1
phosphorylation, may be important for mitotic events that are
distinct from those occurring at the Golgi apparatus. A reduced
pool of GBF1-catalysed active ARF at the Golgi would allow
release of factors from the membrane and their recruitment to
distal sites where they carry out their mitosis-specific functions,
that in turn are required for cell-cycle progression. It is also
possible that reduced levels of ARF–GTP may influence Golgi
events other than COPI-mediated vesicle budding.
We found that GBF1 is phosphorylated by CDK1–cyclin
B. Inhibition of MEK1 failed to affect phosphorylation
arguing against downstream MAPKs as relevant GBF1 kinases.
However, we cannot exclude a role for other kinases in GBF1
phosphorylation. We identified GBF1 as a Plk1 PBD-binding
partner, suggesting that GBF1 can bind to Plk1 in mitosis.
Thus it is possible that Plk1 can phosphorylate GBF1, which
may occur after initial priming phosphorylation by CDK1 on
Plk1 PBD recognition sites. Alternatively, binding of Plk1 to
GBF1 in mitosis may simply target the kinase to regions of
the Golgi involved in COPI vesicle budding, at least at early
stages of mitosis when the majority of GBF1 has yet to dissociate
from the membrane. This would suggest that Plk1 can be
recruited to the Golgi through binding to several Golgi proteins,
including GRASP65 and Rab1 [51]. The large number of Golgi
phosphoproteins isolated in our Plk1 PBD-binding experiments
supports this possibility. This may ensure that relevant targets
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on distinct regions and functional domains of the Golgi are
phosphorylated in an appropriate and timely manner.
Despite several attempts we were unable to identify the mitosis-
specific phosphorylation sites in GBF1. Deletion of the C-
terminal 59 residues of GBF1 abrogated mitotic phosphorylation,
suggesting that sites within this region are phosphorylated.
However, mutation of all eight potential sites in this region failed
to prevent GBF1 phosphorylation, suggesting that this region is
required for recognition by CDK1 and possibly other kinases.
Interestingly there are another six potential CDK1 sites immedi-
ately upstream of this region, some of which may correspond to
the GBF1 phosphorylation sites, although it is equally possible
that CDK1 sites in other parts of the protein are the ones that
are phosphorylated. Using MS we could identify several GBF1
phosphorylation sites, including Ser1298, Ser1318, Ser1320, Ser1335
and Thr1337, but all of these sites were phosphorylated to the
same degree in both interphase and mitosis (results not shown).
Thr1337 was previously shown to be phosphorylated by AMPK
(AMP-activated protein kinase) when cellular AMP levels are
elevated, and to trigger Golgi disassembly under these conditions
[62]. Our results suggest that Thr1337 is also phosphorylated
constitutively in interphase cells, and that the steady-state levels of
phosphorylation at this site do not disassemble the Golgi. Several
large-scale proteomics studies have identified additional GBF1
phosphorylation sites, of which only four (Ser314, Ser599, Tyr1316
and Ser1773) appear to be mitosis-specific and conserved between
mammals [58,59,63]. Of these, two are potential CDK1 sites
(Ser314 and Ser1773), although both lack the basic residue found
in the CDK1 consensus site S/T-P-X-R/K. Additional studies will
be required to identify the mitosis-specific phosphorylation sites
in GBF1 that regulate membrane binding.
How might phosphorylation of GBF1 cause its release from
the membrane? GBF1 binds to several proteins, including p115,
Rab1b and γ -COP [40–42]. It has been proposed that direct
binding to Rab1b is required for membrane recruitment of GBF1.
However, despite numerous attempts, we were unable to detect
binding of GBF1 to Rab1b, or indeed Rab1a (Y. Morohashi, Z.
Balklava and M. Lowe, unpublished work). It therefore possible
that Rab1b acts indirectly to recruit GBF1 to the membrane,
possibly through recruiting effectors to which GBF1 can bind.
One such effector is p115, but previous work has shown that
p115 is not required for targeting GBF1 to the membrane [41]
suggesting that an as yet unidentified Rab1 effector is involved.
Further investigation of how GBF1 binds to the membrane will
be required to determine how it is recruited in interphase, and in
turn how this is regulated by mitotic phosphorylation.
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Phosphorylation and membrane dissociation of the ARF exchange factor
GBF1 in mitosis
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Figure S1 Localization of GBF1 in mitotic cells
(A) NRK cells were synchronized to enrich for mitotic cells and analysed by immunofluorescence microscopy with antibodies against GBF1 (green) and GM130 (red). (B) Unsynchronized HeLa
cells were analysed by immunofluorescence microscopy with antibodies against GBF1 (green) and GM130 (red). DNA is blue in the merged images. Asterisks indicate interphase cells. Scale bars,
10 μm.
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Figure S2 Localization of ARF1–GFP in interphase and mitotic cells
HeLa cells transiently expressing ARF1–GFP (green) were left untreated or treated for 5 min with 5 μg/ml BFA, fixed and labelled with antibodies against GBF1 or GM130 (red). DNA is blue in the
merged images. The asterisk indicates an interphase cell. Scale bar, 10 μm.
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Mitotic phosphorylation of GBF1
Figure S3 COPI membrane association kinetics in interphase and mitosis
NRK cells stably expressing GFP-tagged ε-COP were analysed by FRAP and the fluorescence recovery rate under interphase (A) or mitotic (B) conditions was analysed. (C) Plot of fluorescence
recovery rates for individual interphase and mitotic cells. The average recovery rate is indicated by a horizontal line. (D) Example of a single FRAP experiment performed on an interphase (top panels)
and mitotic (bottom panels) cell. Scale bar, 4 μm.
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